CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs – GlobeNewswire (press release)
CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory AffairsGlobeNewswire (press release)ZUG, Switzerland and CAMBRIDGE, MA., April 04, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical compan… Continue reading
